Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederema.europa.eu
Human medicines: European public assessment reports (EPARs)
Get the latest updates from Human medicines: European public assessment reports (EPARs) directly as they happen.
Follow now 228 followers
Latest posts
Last updated about 12 hours ago
Human medicines European public assessment report (EPAR): Dacogen, decitabine, Date of authorisation: 20/09/2012, Revision: 17, Status: Authorised
about 14 hours ago
Human medicines European public assessment report (EPAR): Dacogen, decitabine, Date of authorisation...
Human medicines European public assessment report (EPAR): Pluvicto, lutetium (177Lu) vipivotide tetraxetan, Date of authorisation: 09/12/2022, Revision: 7, Status: Authorised
about 14 hours ago
Human medicines European public assessment report (EPAR): Pluvicto, lutetium (177Lu) vipivotide tetraxetan...
Human medicines European public assessment report (EPAR): Lutathera, lutetium (177Lu) oxodotreotide, Date of authorisation: 26/09/2017, Revision: 13, Status: Authorised
about 14 hours ago
Human medicines European public assessment report (EPAR): Lutathera, lutetium (177Lu) oxodotreotide, Date...
Human medicines European public assessment report (EPAR): Moventig, naloxegol, Date of authorisation: 07/12/2014, Revision: 17, Status: Authorised
about 15 hours ago
Human medicines European public assessment report (EPAR): Moventig, naloxegol, Date of authorisation...
Human medicines European public assessment report (EPAR): Dabigatran etexilate Teva (previously Dabigatran etexilate Leon Farma), dabigatran etexilate, Date of authorisation: 19/02/2024, Revision: 2, Status: Authorised
1 day ago
Human medicines European public assessment report (EPAR): Dabigatran etexilate Teva (previously Dabigatran...
Human medicines European public assessment report (EPAR): Optruma, raloxifene, Date of authorisation: 05/08/1998, Revision: 27, Status: Authorised
1 day ago
Human medicines European public assessment report (EPAR): Optruma, raloxifene, Date of authorisation...
Human medicines European public assessment report (EPAR): Cinryze, C1 inhibitor (human), Date of authorisation: 15/06/2011, Revision: 24, Status: Authorised
1 day ago
Human medicines European public assessment report (EPAR): Cinryze, C1 inhibitor (human), Date...
Human medicines European public assessment report (EPAR): Giapreza, angiotensin II, Date of authorisation: 23/08/2019, Revision: 6, Status: Authorised
2 days ago
Human medicines European public assessment report (EPAR): Giapreza, angiotensin II, Date of...
Human medicines European public assessment report (EPAR): Tuznue, trastuzumab, Date of authorisation: 19/09/2024, Status: Authorised
2 days ago
Human medicines European public assessment report (EPAR): Tuznue, trastuzumab, Date of authorisation...
Human medicines European public assessment report (EPAR): Tuznue, trastuzumab, Date of authorisation: 19/09/2024, Status: Authorised
2 days ago
Human medicines European public assessment report (EPAR): Tuznue, trastuzumab, Date of authorisation...
Human medicines European public assessment report (EPAR): Hemgenix, etranacogene dezaparvovec, Date of authorisation: 20/02/2023, Revision: 4, Status: Authorised
3 days ago
Human medicines European public assessment report (EPAR): Hemgenix, etranacogene dezaparvovec, Date of...
Human medicines European public assessment report (EPAR): Zoonotic Influenza Vaccine Seqirus, Zoonotic influenza vaccine (H5N8) (surface antigen, inactivated, adjuvanted), Date of authorisation: 09/10/2023, Revision: 2, Status: Authorised
3 days ago
Human medicines European public assessment report (EPAR): Zoonotic Influenza Vaccine Seqirus, Zoonotic...